Prostate cancer ranks as the second most common cancer in men globally, and presents unique challenges in Kuwait. Experts estimate that up to 89% of men who live up to the age of 80 years will develop prostate cancer at some point. In recognition of Men’s Health Awareness Month, there is a growing focus on raising awareness of prostate cancer and promoting early detection, which can significantly improve treatment outcomes through early diagnosis.
According to the Global Cancer Observatory, prostate cancer was the most common cancer among Kuwaiti men in 2022, accounting for 12.9% of all new cancer cases in males, with 274 new cases reported. Prostate cancer was histologically confirmed in 42 (27.4%) patients at Al Amiri Hospital and the risk of developing prostate cancer between the age of 66 – 75 was 33.3%. These statistics highlight the critical need for increased awareness and early detection.
Prostate cancer presents complexities that vary by region, age, ethnicity, and race. In Kuwait, the challenges include cultural perceptions and limited awareness, which often prevent men from seeking early screening and treatment. In contrast to regions like Europe and North America, where extensive research has informed understanding of the disease, prostate cancer in the Middle East remains significantly less understood. Barriers such as limited cancer registries, cultural constraints to healthcare access, and varied healthcare systems across the countries in this region further complicate the issue.
Dr Yaser Hasan, Chairman of the Radiation Oncology Department, Kuwait Cancer Control Center (KCCC) said: "Prostate cancer remains one of the most treatable cancers if caught early, yet cultural barriers and limited awareness often prevent men from seeking essential screenings. Early detection is crucial for improving outcomes, and by making it a standard practice, we can significantly reduce late-stage diagnosis, offering men and their families hope for longer, healthier lives. Early detection is not just a medical recommendation, it’s a call to action for all of us in Kuwait to protect and prioritize men’s health and well-being.”
Screening for prostate cancer has evolved significantly, offering new hope for early detection and effective management. Screening methods primarily involve two tests: the prostate-specific antigen (PSA) blood test and the digital rectal exam (DRE). The PSA test measures the level of PSA, a protein produced by the prostate, in the blood. Elevated PSA levels can indicate the presence of prostate cancer, prompting further investigation. The DRE, where a doctor feels the prostate for abnormalities, can also help detect potential issues. Screening is particularly recommended for men over 50, or earlier for those with a family history of prostate cancer or higher risk factors, as early detection improves treatment success rates.
In addition to screening and early detection, understanding the symptoms and causes of prostate cancer is crucial for effective prevention and management. Often referred to as the "silent threat”, prostate cancer can develop without showing any noticeable symptoms in its early stages, allowing the prostate cancer cells to grow within the prostate gland without causing the individual any warning signs. The lack of symptoms can make early detection challenging, as the disease can go unnoticed until it reaches an advanced stage. As prostate cancer progresses, it may cause symptoms such as difficulty urinating, blood in the urine or semen, bone pain, weight loss, and erectile disfunction.
Pedro Matos Rosa, General Manager, Johnson & Johnson Innovative Medicine, Gulf, said: "Our mission is to improve healthcare outcomes by increasing awareness and making screening more accessible. At Johnson & Johnson, our commitment goes beyond providing treatments; it’s about raising awareness, challenging cultural norms, and ensuring that early detection becomes a standard practice for men across Kuwait. By working hand-in-hand, we are dedicated to removing barriers to care and creating a future where prostate cancer is detected early and managed effectively.”
Raising awareness, promoting regular screenings, and using innovative treatments are essential steps in improving prostate cancer outcomes in Kuwait. It is pivotal for individuals to take proactive measures, stay informed, and advocate for early detection. By fostering a culture of proactive health and collective action, Kuwait can make significant strides in reducing the impact of prostate cancer and improving the lives of those affected by it.